Errors happen in drug making. But quality testing helps prevent them from reaching the public.
Americans have unrealistic expectations of how COVID-19 vaccines should be made.
Lower doses could save more lives, some oncologists say.
The tech, which has saved tens of millions of lives over time, keeps getting better.
A new wave of studies convinced the US government to make the drug an option for non-pediatric hospitalized patients.
Expectant mothers have long been excluded from clinical trials. Some experts say this practice needs to change.
Pharmaceutical companies need to be more transparent about excipients like fillers for the sake of patient safety.
Much like early Lyme testing, the coronavirus is a reminder that diagnostics aren’t perfect.
Is a price tag of $40 too high to save a life?
How medicine is made: the nitty-gritty of drug research and development.
Like science, tech, and DIY projects?
Sign up to receive Popular Science's emails and get the highlights.